English正體中文
About
About
TACTC Forum & TCTI 2026, themed “Investigator-Initiated Trials: Accelerating the Next Wave of Clinical Innovation,” will explore current developments and practical approaches to investigator-initiated trials (IITs).
What are IITs?
What are IITs?
An investigator-initiated trial (IIT) is a clinical study conceived and led by a researcher in response to a clinical observation, unmet medical need, or scientific question. The investigator typically assumes responsibility for developing the research concept, designing the study, and overseeing its conduct.
MORE
Hightlights
Hightlight
Global Perspectives on IITs
Experts from Taiwan, Japan, South Korea, the United Kingdom, and the global clinical research community will share their experience and perspectives on advancing IITs.
Connecting Policy, Industry, and IIT Operations
The morning program will explore the policy, industry, and operational foundations required to advance IIT development through sessions on National Enablers, Industry Synergy, and Operational Excellence.
TACTC Spotlight
Presentations and exhibits by TACTC member institutions will showcase their research strengths, clinical trial capabilities, and IIT experience, creating opportunities for exchange and collaboration across institutions.
Taiwan IIT Innovation & Collaboration Marketplace
The afternoon marketplace will feature three thematic zones where research teams can connect with clinical partners, explore potential funding resources, and engage with industry representatives.
Organizer
Organizer
TACTC臺灣臨床試驗中心聯盟
臺北醫學大學
人體研究處
TOP